Unknown

Dataset Information

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.


ABSTRACT:

Purpose

Immune checkpoint inhibitors (ICIs) have recently emerged as an important option for treating patients with advanced non-small cell lung cancer (NSCLC). Neoantigens are important biomarkers and potential immunotherapy targets that play important roles in the prognosis and treatment of patients with NSCLC. This study aimed to evaluate and characterize the relationships between somatic mutations and potential neoantigens in specimens from patients who underwent surgical treatment for NSCLC.

Patients and methods

This prospective study evaluated specimens from patients with NSCLC who underwent surgical treatment at the Peking Union Medical College, China, from June 2019 to September 2019. Whole-exome sequencing was performed for tumor tissues and corresponding normal tis

SUBMITTER: Liang H 

PROVIDER: S-EPMC8959482 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature